Literature DB >> 3102552

Comparison of TRACK XI fluorometric immunoassay system with other serologic tests for detection of serum antibody to Brucella abortus in cattle.

S M Hall, A W Confer.   

Abstract

The TRACK XI system (TRACK) is a commercially available fluorometric immunoassay system that has been adapted for the detection of antibodies to several antigens in various animal species. Serum antibodies to Brucella abortus were detected by TRACK and compared with those obtained from two primary binding assays (a fluorometric immunoassay [FIAX] and an enzyme-linked immunosorbent assay) and three standard serological tests (complement fixation, Rivanol precipitation, and CARD tests). A total of 298 serum samples were tested by each serological test. Of these serum samples, 134 were negative controls, 43 were from cattle 1 month after vaccination with B. abortus 19, and 121 were from cattle 10 to 12 weeks after a midgestational, intraconjunctival challenge with B. abortus 2308. The results of this study indicated that TRACK is both reproducible and accurate. The results compared favorably with those of other serological methods. TRACK is more rapid than either the enzyme-linked immunosorbent assay or FIAX system. TRACK was the most sensitive (96.3%) test, with a specificity of 100%.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3102552      PMCID: PMC265898          DOI: 10.1128/jcm.25.2.350-354.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Effect of reduced dosages of Brucella abortus strain 19 in cattle vaccinated as yearlings.

Authors:  B L Deyoe; T A Dorsey; K B Meredith; L Garrett
Journal:  Proc Annu Meet U S Anim Health Assoc       Date:  1979

Review 2.  Validation of screening procedures.

Authors:  A L Cochrane; W W Holland
Journal:  Br Med Bull       Date:  1971-01       Impact factor: 4.291

3.  Statistics for diagnostic procedures. I. How sensitive is "sensitivity"; how specific is "specificity"?

Authors:  W C Phillips; J A Scott; G Blasczcynski
Journal:  AJR Am J Roentgenol       Date:  1983-06       Impact factor: 3.959

4.  Latent carriers of brucellosis.

Authors:  L A Dolan
Journal:  Vet Rec       Date:  1980-03-15       Impact factor: 2.695

5.  The serological diagnosis of bovine brucellosis.

Authors:  W J Morgan
Journal:  Vet Rec       Date:  1967-05-27       Impact factor: 2.695

6.  Evaluation of the enzyme-linked immunosorbent assay for detecting Brucella abortus antibodies.

Authors:  J W Byrd; F C Heck; R J Hidalgo
Journal:  Am J Vet Res       Date:  1979-06       Impact factor: 1.156

Review 7.  Recent progress in the diagnosis of brucellosis.

Authors:  B W Stemshorn
Journal:  Dev Biol Stand       Date:  1984

8.  Biochemical and biological properties of soluble protein preparations from Brucella abortus.

Authors:  L B Tabatabai; B L Deyoe
Journal:  Dev Biol Stand       Date:  1984

9.  Characterization of Brucella abortus soluble antigen employed in immunoassay.

Authors:  D T Berman; B L Wilson; E Moreno; R D Angus; L M Jones
Journal:  J Clin Microbiol       Date:  1980-04       Impact factor: 5.948

10.  Effects of challenge dose on the clinical and immune responses of cattle vaccinated with reduced doses of Brucella abortus strain 19.

Authors:  A W Confer; S M Hall; C B Faulkner; B H Espe; B L Deyoe; R J Morton; R A Smith
Journal:  Vet Microbiol       Date:  1985-12       Impact factor: 3.293

View more
  2 in total

1.  Simultaneous identification of antibodies to Brucella abortus and Staphylococcus aureus in milk samples by flow cytometry.

Authors:  D Iannelli; L D'Apice; D Fenizia; L Serpe; C Cottone; M Viscardi; R Capparelli
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

2.  Comparison of Track XI fluorometric immunoassay with Bio-EnzaBead enzyme-linked immunosorbent assay for detection of serum antibody to mouse hepatitis virus.

Authors:  M C La Regina; J Lonigro; L Woods; W C Hall; R E Doyle
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.